ADVERTISEMENT

Early-stage NSCLC: presence of EGFR mutation predicts longer OS in nationwide study

Miriam Davis, PhD   |   Clinical Summary   |   29 June 2022
ADVERTISEMENT

Takeaway

  • A nationwide population-based study of Danish patients with early-stage (stage I-IIIA) NSCLC finds that the presence of a mutation in the epidermal growth factor receptor gene ( EGFR m-positivity) is associated with longer median OS than  EGFR m-negativity.
  • Despite this finding, most patients (54%) are not tested for  EGFR...

          

January Challenge

Ends in 2d 15h
left
right

Topic Challenges

left
right